Judge José Luis Calama of the National Court, who is investigating the Grifols case, has asked the National Securities Market ...
The actor’s charitable foundation has just unlocked the key to flagging Parkinson’s disease early, putting us one step closer ...
European equities traded in the US as American depositary receipts were advancing on Thursday morning, up 0.5% to 1,346.74 on the S&P Europe Select ADR Index. From continental Europe, the gainers were ...
Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator ...
Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in court.
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...
The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...
Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
Abbott Laboratories, Novartis, and Grifols have reached a settlement in their long-running legal battle over a patent ...
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
Will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years.
Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based ...